|Project Title||Cardiovascular Therapy Agent Use 2|
Tuesday, September 23, 2014
Summary table assessment of the incident and prevalent use of twenty-four cardiovascular therapy agents two generic drugs, acebutolol HCL, aliskiren hemifumarate, amlodipine besylate, ambrisentan, atenolol, betaxolol HCL, bosentan, captopril, carvedilol, conivaptan HCL, diltiazem HCL, eprosartan mesylate, indapamide, labetalol HCL, lisinopril, metoprolol succinate, metoprolol tartrate, metoprolol/hydrochlorothiazide, nadolol, nimodipine, perindopril erbumine, propafenone HCL, trandolapril, and triamterene. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in 8/19/2013. The data contained in this report include individuals Aged 0-18 from 16 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.
cardiovascular therapy agent
2000 - 2012
Mini-Sentinel Distributed Database (MSDD)